Use sensitive patient data securely with compliance through cryptography

}
11 November 2023

Studies on various topics, such as sleep habits, the effects of certain diseases or sports, and brain research, utilize clinically sensitive patient data. Many of these studies require first-party access to databases for data manipulation – even though they only need the results of database queries.

The key challenge in processing patient data

In recent years, sleep medicine, brain research, and other domains have experienced a surge in interest in machine and deep learning-related research. These cutting-edge projects involve clinically sensitive data, sparking discussions on multiple fronts. A key challenge is finding the right balance between research openness, privacy concerns, and data security. This is a tricky task, to say the least. Research projects must adhere to the FAIR data principles. These are about ensuring that the data is findable, accessible, interoperable, and reusable. At the same time, researchers also must comply with the stringent General Data Protection Regulation (GDPR) of 2016/679.

The primary challenge is that GDPR places a strong emphasis on data privacy, necessitating explicit consent from individuals for data usage. While crucial for protecting individuals’ rights and privacy, this requirement sometimes conflicts with the openness and accessibility advocated by FAIR principles. Researchers often face a dilemma, aiming to make data findable and accessible while ensuring strict privacy compliance. Strict security protocols impede collaborative research as institutions can’t exchange data.

What is the reaction of the medical community?

Navigating this terrain isn’t easy. GDPR compliance can seem burdensome, especially for observational data. The balancing act involves making data available for advancements while safeguarding individuals’ privacy and maintaining the highest data security standards. It’s a tough challenge. The International Network of Privacy Law Professionals argues thatscientific research should not be unduly held back by data protection interests and legislation.” The reality is that medical researchers are hindered by GDPR, and the debate continues at both the European Union and member state levels. In this evolving landscape, researchers and institutions continually strive to adapt to meet these challenges. The ultimate goal is to harness the power of data-driven insights without compromising ethical standards—a journey of innovation and responsibility where medical research seeks to improve lives while respecting individuals’ privacy and data security.

Use sensitive patient data without consent

Confidential Cloud emerges as a game-changer in this scenario, providing a secure environment for managing and sharing sensitive data. It ensures data remains protected while remaining accessible for research purposes. Confidential Cloud enables harnessing the power of data without requiring patient consent, all without contradicting GDPR regulations.

 

YOU MAY ALSO LIKE …

Enhancing the circularity of electric vehicle batteries

Enhancing the circularity of electric vehicle batteries

REmanufacture, REcycle, REuse and REduce: Mälardalen University is addressing these four main aspects of Circular Economy in a new project enabling circularity of electric batteries. It runs the project in close collaboration with the Swedish industry. The Circul8...

CanaryBit supports Mobility industry leaders

CanaryBit supports Mobility industry leaders

CanaryBit is one of the eight startups selected for batch 10 of the MobilityXlab programme. The programme aims to co-create solutions with seven mobility industry leaders: CEVT, Ericsson, Polestar, Veoneer, Volvo Cars, Volvo Group, and Zenseact. The competition was...

2022: still growing, still independent, still us!

2022: still growing, still independent, still us!

Still growing. In our 2021 end-of-the-year message, we highlighted that growth will be the theme of 2022. And so it was. Both founders started working 100% on CanaryBit in January. It was a challenging year in many respects, but our ideas and solutions were validated...